# Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

> **NCT06052072** · NA · RECRUITING · sponsor: **Gradient Denervation Technologies** · enrollment: 50 (estimated)

## Conditions studied

- Group 2 Pulmonary Hypertension
- Heart Failure

## Interventions

- **DEVICE:** Gradient Denervation System

## Key facts

- **NCT ID:** NCT06052072
- **Lead sponsor:** Gradient Denervation Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-20
- **Primary completion:** 2026-06
- **Final completion:** 2028-07-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06052072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06052072, "Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06052072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*